{"title":"Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany","link":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0303776","date":1715263200000,"content":"<p>by Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum</p>","author":"Florian Schwarz","siteTitle":"PLOS ONE","siteHash":"e9ab556ceb1e4ea76e897a5fa4f394f0bb75c2c2f3d5b0f4766ff77b4a262ac1","entryHash":"42987bda16c33125cbf070c7f9a56ab5dc4d77b41a4260d71b7686bb9687e272","category":"Interdisciplinary"}